Therefore, targeting the CRABP1–MAPK signalosome may provide a means to selectively reduce the secretion of pro-inflammatory exosomes, potentially mitigating neuroinflammation in certain neurodegenerative diseases. This evidence concerns the gene CRABP1 and neurodegenerative disease.